Dmitrij Hristodorov

Statistics

Publications

Citations

412

H-Index

Active since

2012

Affiliations

Fraunhofer Institute for Molecular Biology and Applied Ecology(Current)

RWTH Aachen University

University of Cape Town

University Medical Center Groningen

Universitätsklinikum Aachen

Dmitrij Hristodorov is an author at Fraunhofer Institute for Molecular Biology and Applied Ecology specializing in cancer immunotherapy, therapeutic targeting of fusion proteins, and immunotherapy.

Publications per year

2012–2016

Publications

Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies

Dmitrij Hristodorov, Radoslav Mladenov, Verena von Felbert et al. · mAbs · 2015 · 79 citations · Full text

Life Sciences, Immunology, Pathology +15

Generation and Comparative Characterization of Glycosylated and Aglycosylated Human IgG1 Antibodies

Dmitrij Hristodorov, Rainer Fischer, Hannah Joerissen et al. · Molecular Biotechnology · 2012 · 73 citations

Pharmacy, Biochemistry, Molecular Biology +14

Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model

Manal Amoury, Katharina Kolberg, Anh‐Tuan Pham et al. · Cancer Letters · 2016 · 43 citations

Medicine, Oncology, Pharmacology +13

Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo

Dmitrij Hristodorov, Rumen Mladenov, Alessa Pardo et al. · British Journal of Cancer · 2013 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein

Manal Amoury, Radoslav Mladenov, Thomas Nachreiner et al. · International Journal of Cancer · 2016 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +14

1–5 of 14